Recommended

Sarepta’s DMD drug Elevidys issued FDA label update
Rare disease gene therapy granted European first approval
Johnson & Johnson agrees $3bn oncology acquisition
European Commission grants EU first for J&J’s Simponi biosimilar
Researchers validate approach that supports animal-based pyrogen test replacement
ON DEMAND webinar: automating QC testing for radiopharmaceutical production
Insmed secures EU approval for Brinsupri (brensocatib)
Moderna invests over $140m to onshore mRNA medicine manufacturing in US
news

Developing easy-to-swallow medicine for children

23
SHARES

A study has revealed an in vitro method that could screen various compounds, identifying ones that would make swallowing medicine easier…

swallow

A study has compared traditional sensory tests and an in vitro method that could explain why smaller multiparticles would ease the journey from mouth to throat into the body.

 

Reserve your FREE place

 


Address the time-to-result challenge posed by short shelf-life radiopharmaceuticals.

20 November 2025 | 3:00 PM GMT | FREE Virtual Panel Discussion

This webinar showcases the Growth Direct System; an RMM (Rapid Microbial Method) that improves on traditional membrane filtration, delivering increased accuracy, a faster time to result, enhanced data integrity compliance, and more control over the manufacturing process.

Key learning points:

  • Understand the benefits of full workflow microbiology quality control testing automation in radiopharmaceutical production
  • Learn about ITM’s implementation journey and considerations when evaluating the technology
  • Find out how the advanced optics and microcolony detection capabilities of Growth Direct® technology impact time to result (TTR).

Don’t miss your chance to learn from experts in the industry – Register for FREE

 

The test allowed scientists to screen different compositions of the carrier liquid, and the composition of the particles in order to make swallowing easier.

Co-author of the study and Senior Lecturer at the University of Surrey, Dr Marco Ramaioli, said: “Many young children and older people find conventional tablets hard to swallow – making it difficult for them to complete drug therapy. We hope that this in vitro method, together with sensory tests, will help to develop novel medicines that could improve the lives of many people across the world.”

Professor Catherine Tuleu at the UCL School of Pharmacy said: “It is exciting to see advancements in age appropriate medicine design such as multiparticulate systems but successful therapeutic outcomes rely on the development of appropriate administration vehicles.”

Dr Mine Orlu, also from UCL School of Pharmacy, added: “The availability of predictive models to characterise the promising formulation platforms early during medicine development is key to producing medicines that are easier to take for patients with different swallowing capabilities.”

The study was published by the European Journal of Pharmaceutical Sciences.

Share via
Share via